Get the Stockscreener App
1.19
5.56%
-0.07
Bionexus Gene Lab Corp stock is traded at $1.19, with a volume of 1,209.
It is down -5.56% in the last 24 hours and down -17.36% over the past month.
BioNexus Gene Lab Corp is a Wyoming corporation with two principal operating subsidiaries in Malaysia: Chemrex Corporation Sdn. Bhd. (Chemrex) and MRNA Scientific Sdn. Bhd. (MRNA Scientific). Chemrex is engaged in the distribution of chemical raw materials, mainly for industrial applications in Southeast Asia. MRNA Scientific is engaged in the development and provision of blood-based genomic screening services intended to support early disease risk assessment and health management. Trading of industrial chemicals- Includes trading of industrial chemicals. Provision for genomic screening services- includes in commercializing proprietary blood-based diagnostic test for early disease detection. Investment holding- Investment holding, are its segments.
See More
Previous Close:
$1.26
Open:
$1.1977
24h Volume:
1,209
Relative Volume:
0.08
Market Cap:
$3.49M
Revenue:
$5.31M
Net Income/Loss:
$-2.90M
P/E Ratio:
-0.8011
EPS:
-1.4855
Net Cash Flow:
$-1.18M
1W Performance:
-4.75%
1M Performance:
-17.36%
6M Performance:
-45.41%
1Y Performance:
-77.07%
1-Day Range:
$1.19
$1.1977
1-Week Range:
$1.20
$1.39
52-Week Range:
$1.07
$5.8876
Bionexus Gene Lab Corp Stock (BGLC) Company Profile
Name
Bionexus Gene Lab Corp
Sector
Industry
Phone
1-307-241-6898
Address
10-2 TOWER B, VERTICAL BUSINESS SUITE,, KUALA LUMPUR
Compare BGLC vs LIN, ECL, SHW, APD, PPG
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BGLC
Bionexus Gene Lab Corp
|
1.19 | 3.49M | 5.31M | -2.90M | -1.18M | -1.4855 |
LIN
Linde Plc
|
494.58 | 227.99B | 34.66B | 7.25B | 5.10B | 15.07 |
ECL
Ecolab Inc
|
292.12 | 81.89B | 16.45B | 2.12B | 1.87B | 7.3955 |
SHW
Sherwin Williams Co
|
336.39 | 81.66B | 23.94B | 2.60B | 2.91B | 10.42 |
APD
Air Products Chemicals Inc
|
295.13 | 65.72B | 12.46B | 2.16B | -1.25B | 9.454 |
PPG
Procter Gamble Co
|
107.86 | 23.98B | 16.12B | 1.59B | 1.23B | 6.9799 |
Bionexus Gene Lab Corp Stock (BGLC) Latest News
BioNexus to Build AI Applications for Malaysian Healthcare Under Exclusive CogniAI Licence - FinancialContent
Ruanyun Edai Technology Announces Definitive Agreement to License Cogni AI to BioNexus Gene Lab for Malaysian Healthcare Market - Quiver Quantitative
RYET to Enter Malaysian Healthcare Through Exclusive Cogni AI License to BioNexus Gene Lab - GlobeNewswire Inc.
Nasdaq Firm Makes Historic Shift to Ethereum-Based Treasury - Yellow.com
Nasdaq Firm Makes Historic Shift to Ethereum-Based Treasury - Yellow.com
Nasdaq Firm Makes Historic Shift to Ethereum-Based Treasury - Yellow.com
12 Industrials Stocks Moving In Friday's Pre-Market Session - Benzinga
Nasdaq Firm Makes Historic Shift to Ethereum-Based Treasury - Yellow.com
Nasdaq Firm Makes Historic Shift to Ethereum-Based Treasury - Yellow.com
11 Industrials Stocks Moving In Wednesday's After-Market Session - Benzinga
Jook Yuen Low Net Worth (2026) - GuruFocus
Set Fui Chong Net Worth (2026) - GuruFocus
Fidelion Diagnostics Pte. Ltd. Net Worth (2026) - GuruFocus
Bin Abdul Hamid Muhammad Azrul Net Worth (2026) - GuruFocus
BioNexus Gene Lab Revenue Collapses 97% in Q2 as Major Customer Lost - minichart.com.sg
BioNexus Gene Lab Corp (BGLC) CEO reports 338,709-share award and 11.5% stake - Stock Titan
BioNexus Gene Lab Corp (BGLC) grants CEO 338,709 fully vested shares - Stock Titan
BioNexus Gene Lab Corp (BGLC) director receives 32,258-share fully vested award - Stock Titan
BioNexus Gene Lab Corp (BGLC) director receives 32,258-share equity award - Stock Titan
BioNexus Gene Lab Corp (BGLC) CFO receives 96,774-share equity award - Stock Titan
BioNexus Gene Lab Corp (BGLC) director granted 16,129-share fully vested stock award - Stock Titan
BioNexus Gene Lab Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
Nasdaq Firm Makes Historic Shift to Ethereum-Based Treasury - Yellow.com
Nasdaq Firm Makes Historic Shift to Ethereum-Based Treasury - Yellow.com
Nasdaq Firm Makes Historic Shift to Ethereum-Based Treasury - Yellow.com
Nasdaq Firm Makes Historic Shift to Ethereum-Based Treasury - Yellow.com
Nasdaq Firm Makes Historic Shift to Ethereum-Based Treasury - Yellow.com
BioNexus Gene Lab files initial beneficial ownership statement for Fidelion Diagnostics Pte. Ltd - Bitget
Fidelion Diagnostics reports 392,329 BioNexus Gene Lab Corp (NASDAQ: BGLC) shares - Stock Titan
BioNexus Gene Lab Corp (BGLC) Stock News Today - TradingKey
BioNexus Gene Lab Corp (BGLC) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
BioNexus Gene Lab files initial beneficial ownership statement for Fidelion Diagnostics Pte. Ltd - Bitget
BioNexus Gene Lab (BGLC) Surges 8.3% to $1.43: Can Momentum Break the $1.50 Ceiling?Volume Climax - dars.gov.et
BioNexus Gene Lab (BGLC) director discloses 1,261 common shares in Form 3 - Stock Titan
BioNexus Gene Lab (BGLC) director files Form 3 with zero shares - Stock Titan
BioNexus Gene Lab Corp (BGLC) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
BioNexus Says VitaGuard Blood Tests Could Cost Under $300 - Stock Titan
BioNexus Advances VitaGuard™ Southeast Asia Rollout Following China Working Visit - GlobeNewswire
BGLC|BioNexus Gene Lab Corp|Price:1.370|Chg%:-0.140 - TradingKey
BGLC|BioNexus Gene Lab Corp|Price:1.450|Chg%:-0.060 - TradingKey
BioNexus Gene Lab Corp Revenue Breakdown – NASDAQ:BGLC - TradingView
BioNexus Gene Lab Corp (BGLC) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
BioNexus Gene Lab Corp (BGLC) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
BGLC|BioNexus Gene Lab Corp|Price:1.510|Chg%:-0.050 - TradingKey
BioNexus Gene Lab Corp (BGLC) Cash Flow - TradingKey
TradingKey - TradingKey
BioNexus Gene Lab Corp (BGLC) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
BioNexus Gene Lab Corp (BGLC) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
BGLC|BioNexus Gene Lab Corp|Price:1.613|Chg%:-0.027 - TradingKey
BioNexus Gene Lab Corp (BGLC) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Bionexus Gene Lab Corp Stock (BGLC) Financials Data
Revenue
Net Income
Cash Flow
EPS
19.16%
3.52%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):